日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions

结直肠癌靶向治疗的进展：克服挑战，探索未来方向

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172810
Khelwatty, Said A; Puvanenthiran, Soozana; Seddon, Alan M; Bagwan, Izhar; Essapen, Sharadah; Modjtahedi, Helmout
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Shining a light on fluorescent EV dyes: Evaluating efficacy, specificity and suitability by nano-flow cytometry

了解荧光 EV 染料：通过纳米流式细胞术评估功效、特异性和适用性

期刊:Journal of Extracellular Biology
影响因子:
doi:10.1002/jex2.70006
Joseph Brealey, Rebecca Lees, Robert Tempest, Alice Law, Sonia Guarnerio, Rawan Maani, Soozana Puvanenthiran, Nick Peake, Ryan Pink, Ben Peacock
细胞生物学
其它细胞
发表日期：2024
文献求助 收藏

HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer

HER2表达可预测接受西妥昔单抗治疗的RAS野生型转移性结直肠癌患者的生存期

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13040638
Khelwatty, Said A; Puvanenthiran, Soozana; Essapen, Sharadah; Bagwan, Izhar; Seddon, Alan M; Modjtahedi, Helmout
肿瘤
肠癌
肿瘤免疫
HER2
RAS
发表日期：2021
文献求助 收藏

Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer

HER家族成员、EGFRvIII、c-MET、CD44在卵巢癌患者中的共表达及其预后意义

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24791
Puvanenthiran, Soozana; Essapen, Sharadah; Haagsma, Ben; Bagwan, Izhar; Green, Margaret; Khelwatty, Said Abdullah; Seddon, Alan; Modjtahedi, Helmout
EGFR
肿瘤
EGF
卵巢癌
CD4
MET
肿瘤免疫
CD44
T细胞
发表日期：2018
文献求助 收藏

Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs

推定的癌症干细胞标志物和生长因子受体表达对卵巢癌细胞对各种形式的小分子酪氨酸激酶抑制剂和细胞毒药物治疗敏感性的影响

期刊:International Journal of Oncology
影响因子:4.5
doi:10.3892/ijo.2016.3678
Soozana Puvanenthiran, Sharadah Essapen, Alan M Seddon, Helmout Modjtahedi
发育与干细胞
肿瘤
卵巢癌
干细胞
发表日期：2016
文献求助 收藏